[ad_1]
The Ministry of Health confirmed 199 more deaths from covid-19 in Colombia, of which 177 correspond to previous days. Thus, for the second day in a row, the daily death toll does not exceed 200 (this Sunday there were 190). With this update, the total number of deaths in the country rises to 23,123.
(You may be interested: The pandemic in Europe will be ‘harder’ in October and November: WHO)
This Monday, September 14, the health authority also reports 5,573 new infections in the last 24 hours, after 22,386 PCR tests and 7,815 antigen tests were processed.
This represents a further decline in the number of daily COVID-19 infections. In the last week, the lowest daily record marked 6,876 infections (Saturday, September 12). The other days the figure exceeded 7 thousand.
It should also be remembered that last September 7 this indicator showed 5,327 daily infections, despite the fact that, as this Monday, the average number of daily tests carried out (between 20,000 and 25,000 PCR and between 7,000 and 10,000 antigen) was maintained. .
(We recommend: In photos: Iraqis unearth the bodies of coronavirus victims)
So things, the country reaches 721,892 confirmed coronavirus cases, after processing a total of 3,194,202 tests since the first contagion (confirmed on March 6).
To date, Bogotá is the city with the most cases. The capital reached the figure of 242,007 confirmed infections after 1,720 more were confirmed this Monday.
(Also: Everything ready for the recruitment of volunteers for the covid vaccine)
This report from the Ministry of Health also indicates that, In the last 24 hours, 7,540 recovered patients were confirmed. Thus, there are already 606,925 patients who, to date, have overcome covid-19 in Colombia.
With this update, in total 90,319 cases remain active in the country.
Related news:
– Covid-19: asymptomatic children or with mild symptoms can transmit it
– They alert for the load of false covid tests that could reach the country
– What is known and ignored in six months of the pandemic
– Oxford Resumes Covid-19 Vaccine Trials
ELTIEMPO.COM
